State Street’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,749
| Closed | -$32K | – | 4948 |
|
|
2022
Q3 | $32K | Hold |
4,749
| – | – | ﹤0.01% | 4755 |
|
|
2022
Q2 | $51K | Hold |
4,749
| – | – | ﹤0.01% | 4722 |
|
|
2022
Q1 | $106K | Buy |
4,749
+199
| +4% | +$4.44K | ﹤0.01% | 4623 |
|
|
2021
Q4 | $127K | Sell |
4,550
-310
| -6% | -$8.65K | ﹤0.01% | 4521 |
|
|
2021
Q3 | $317K | Buy |
4,860
+130
| +3% | +$8.48K | ﹤0.01% | 4168 |
|
|
2021
Q2 | $377K | Sell |
4,730
-6,213
| -57% | -$495K | ﹤0.01% | 3966 |
|
|
2021
Q1 | $1.45M | Sell |
10,943
-264
| -2% | -$35.1K | ﹤0.01% | 3543 |
|
|
2020
Q4 | $1.78M | Buy |
11,207
+74
| +0.7% | +$11.8K | ﹤0.01% | 3410 |
|
|
2020
Q3 | $1.17M | Buy |
11,133
+299
| +3% | +$31.5K | ﹤0.01% | 3396 |
|
|
2020
Q2 | $1.31M | Buy |
10,834
+300
| +3% | +$36.4K | ﹤0.01% | 3338 |
|
|
2020
Q1 | $826K | Buy |
10,534
+41
| +0.4% | +$3.22K | ﹤0.01% | 3350 |
|
|
2019
Q4 | $3.09M | Buy |
10,493
+956
| +10% | +$281K | ﹤0.01% | 3074 |
|
|
2019
Q3 | $1.72M | Buy |
9,537
+50
| +0.5% | +$9.04K | ﹤0.01% | 3266 |
|
|
2019
Q2 | $3.78M | Buy |
9,487
+470
| +5% | +$187K | ﹤0.01% | 2970 |
|
|
2019
Q1 | $4.21M | Buy |
9,017
+359
| +4% | +$168K | ﹤0.01% | 2826 |
|
|
2018
Q4 | $4.16M | Buy |
8,658
+62
| +0.7% | +$29.8K | ﹤0.01% | 2806 |
|
|
2018
Q3 | $5.86M | Buy |
8,596
+379
| +5% | +$259K | ﹤0.01% | 2783 |
|
|
2018
Q2 | $5.61M | Buy |
+8,217
| New | +$5.61M | ﹤0.01% | 2804 |
|